Untargeted metabolomics can decide hereditary variation to improve understanding finding Kumar Jeetendra | July 8, 2020 A family and patient walk into a physician’s office. They expect that the most recent tests will show what’s causing the individual’s disease and finish the diagnostic odyssey they’ve been going through for ages. Possessing a precise identification also suggests that perhaps there’s a remedy that can relieve the individual’s condition. To identify the genetic …
Roche’s HER2 Companion Diagnostic for Breast Cancer: FDA approval Kumar Jeetendra | July 30, 2020 Roche, Basel, Switzerland, has received FDA approval for its Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the human epidermal growth factor receptor 2 (HER2) biomarker in breast cancer and as a companion diagnostic for Herceptin (trastuzumab) therapy. HER2 is an important biomarker sometimes found in breast cancer, and its detection …
FDA authorizes initial two COVID-19 serology tests Kumar Jeetendra | August 2, 2020 Today, the U.S. Food and Drug Administration approved the initial two COVID-19 serology tests which show an estimated amount of antibodies within somebody’s blood. Both tests from Siemens, the ADVIA Centaur COV2G and Attelica COV2G are what are known as”semi-quantitative” evaluations, meaning that they don’t show an exact measurement, but estimate the number of a …
AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes Kumar Jeetendra | August 23, 2020 AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
New analytic instrument may permit on-the-spot recognition of Covid disease Kumar Jeetendra | September 25, 2020 Scientists at the University of Warwick have demonstrated a possible diagnostic tool for detecting Covid-19 using sugars will operate with a virus as opposed to just its proteins, a significant step in making it a viable evaluation in future. Coronavirus diagnostics currently require centralized facilities and collection/distribution of swabs and outcomes are’next day’. A new …
New SARS-CoV-2 IgM assay introduced by Beckman Coulter in countries accepting the CE Mark Kumar Jeetendra | November 12, 2020 Beckman Coulter, a medical diagnostics pioneer, today announced the launching of its accessibility SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The brand new IgM antibody test revealed 99.9% specificity with 1,400 negative trials and 100% sensitivity at >18 times post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is …
Researchers grow first plant-based gel to help organoid development for biomedical applications Kumar Jeetendra | November 26, 2020 Monash University researchers have created the world’s first bioactive plant-based nanocellulose hydrogel to support organoid growth and help significantly reduce the costs of research into cancer and COVID-19. This discovery by researchers in BioPRIA (Bioresource Processing Institute of Australia), Monash University’s Department of Chemical Engineering and the Monash Biomedicine Discovery Institute will develop organoids cheaper, …
CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
Study famous how ecDNA fragments pressure gene amplification to generate drug resistance in cancer Kumar Jeetendra | December 26, 2020 Researchers headed by Ludwig San Diego Member Don Cleveland and Peter Campbell of the Sanger Center have solved the puzzle of how free-floating circular DNA fragments, which are almost exclusively found in cancer cells, drive gene amplification to create drug resistance in cancer. The study, published on December 23 in the journal Nature, provides new …
Surgery may expand length of endurance for metastatic breast malignant growth patients Kumar Jeetendra | December 28, 2020 They studied nearly 13,000 stage four breast cancer patients and found that those who had surgery as well as their other remedies had a survival advantage over those who had other therapies alone. Stage four breast cancer accounts for 6% of newly-diagnosed breast cancer cases. Systemic treatment, which may include treatments like chemotherapy, hormone therapies …
Gene panel test empowers exceptionally exact diagnosis of liposarcomas Kumar Jeetendra | February 5, 2021 Scientists have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel evaluation which allows for highly accurate diagnosis of the most frequent kinds of liposarcoma. The new assay is described in The Journal of Molecular Diagnosis, published by Elsevier. Liposarcomas are a type of malignant cancer that is …
